StrideBio
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- $65M
Investors
- 11
About StrideBio
Based in the US, StrideBio, Inc.StrideBio, Inc. specializes in gene therapy development, particularly utilizing their STRIVE™ Capsid Platform. Founded in 2015 in Durham, US, the company was established by Aravind Asokan and has since conducted 4 total deals.StrideBio develops advanced gene therapies that focus on life-threatening diseases. Their main offerings involve innovative gene therapy products based on the STRIVE™ Capsid Platform, which enhances the delivery of adeno-associated virus (AAV) vectors. The company also possesses advanced AAV manufacturing capabilities, ensuring high-quality production standards.StrideBio generates revenue through strategic partnerships and collaborations with pharmaceutical companies interested in its gene therapy technologies. Their business model centers around B2B transactions, often involving contracts with milestone payments and royalties based on successful product commercialization. Following the acquisition of its AAV Capsid Discovery and Engineering Platform Assets by Ginkgo BioWorks, Inc. in April 2023, the company will focus on launching new products that target previously unmet medical needs. Future plans also involve extending partnerships and collaborations aimed at geographical expansion into Asia by 2025, further bolstering their therapeutic offerings in the global market.
Who invested in StrideBio
11 investors across 3 rounds
See all investors in StrideBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about StrideBio
Who invested in StrideBio?
StrideBio has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has StrideBio raised?
StrideBio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did StrideBio last raise money?
StrideBio's most recent round on record is a Series B, in Mar 2021.
What does StrideBio do?
Based in the US, StrideBio, Inc.
Where is StrideBio headquartered?
StrideBio is headquartered in Durham, US.
Which VCs invest in companies like StrideBio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at StrideBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like StrideBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.